Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-18-036701
Filing Date
2018-06-29
Accepted
2018-06-29 16:32:28
Documents
2
Period of Report
2018-08-22

Document Format Files

Seq Description Document Type Size
1 PRE 14A tv497736_pre14a.htm PRE 14A 155038
2 GRAPHIC tv497736_logo.jpg GRAPHIC 11186
  Complete submission text file 0001144204-18-036701.txt   171689
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36602 | Film No.: 18929675
SIC: 2834 Pharmaceutical Preparations